Hypoxic isolated abdominal perfusion breaks through chemoresistance in recurrent FIGO stage IIIC and IV ovarian Cancer: experience in 143 platinum-refractory and 25 chemonaive ovarian cancer patients - European Journal of Surgical Oncology
↧